Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the irregular heartbeat known as atrial fibrillation—and the sum more than ...

Michael Mahoney; Chairman of the Board, President, Chief Executive Officer; Boston Scientific Corp Daniel Brennan ... as well as reconciliations of the non-GAAP measures used in today's call can be ...

In addition, technological advancements such as the increasing use of AI, predictive analysis, and advanced algorithms are ...

Boston Scientific Corporation ( NYSE: BSX) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO ...

Q4 2024 Earnings Call Transcript February 5, 2025 Operator: Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is ...

Cutting-Edge Cardiac Research: Novoheart’s CTScreen™ system has been installed at UMC Utrecht, equipping Regenerative Medicine Center with advanced high-throughput tools to accelerate human cardiac ...

“These are real consequences, longer waits for cures and for diagnosis, slower scientific ... Trump’s first executive orders has been the target of multiple lawsuits.Credit...Eric Lee/The New York ...